The rapid advance of nanomedicines and biologicals in pharmacotherapy gives increasing importance to a common adverse effect of these modern therapeutics: complement (C) activation-related pseudoallergy (CARPA). CARPA is a relatively frequent and potentially lethal acute immune toxicity of many intravenous drugs that contain nanoparticles or proteins, whose prediction by laboratory or in vivo testing has not yet been solved. Preliminary studies suggest that proneness of the drug to cause C activation in the blood of patients may predict the individual risk of CARPA, thus, a sensitive and rapid bedside assay for individualized assessment of a drug's C activating potential could alleviate the CARPA problem. The goal of the present study was to lay down the foundations of a novel approach for real-time sensing of C activation on a supported lipid bilayer platform. We utilized the quartz crystal microbalance with dissipation (QCM-D) monitoring technique to measure the self-assembly of C terminal complex (or membrane attack complex [MAC]) on supported lipid bilayers rapidly assembled by the solvent-assisted lipid bilayer (SALB) formation method, as an immediate measure of C activation. By measuring the changes in frequency and energy dissipation of deposited protein, the technique allows extremely sensitive real-time quantification of the sequential assembly of MAC from its molecular components (C5b-6, C7, C8 and C9) and hence, measure C activation in the ambient medium. The present paper delineates the technique and our initial evidence with purified C proteins that the approach enables sensitive and rapid (real-time) quantification of MAC formation on a silicon-supported planar (phospho) lipid bilayer, which can be used as an endpoint in a clinically useful bedside C activation assay.
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Introduction
Complement (C) activation-related pseudoallergy (CARPA) is an acute allergy syndrome triggered by intravenous (i.v.) injection or infusion of (nano)medicines, biologicals and many other drugs (1) (2) (3) (4) (5) (6) (7) (8) . The various aspects of this phenomenon, including the features of triggering drugs and agents, its symptoms, kinetics, occurrence, mechanism, prediction, prevention and many other aspects are amply detailed in earlier reviews (3) (4) (5) (6) (7) (8) , as well as in the present special papers on CARPA in the European Journal of Nanomedicine. To reiterate its clinical relevance; CARPA occasionally manifests itself in severe, potentially lethal anaphylactic reaction whose rise is unpredictable, prevention is not fully effective and treatment is nonspecific, empirical at this time. Apart from the medicinal aspects, the problem impacts the pharmaceutical industry as well, because severe reactions and deaths usually draw attention only in late phase clinical trials or in the post-marketing period of reactogenic drugs, at a stage where implementation of changes are not easy. Also, there are already a large number of "CARPA-genic" drugs in clinical use (3) , and prevention of the reactions caused by those drugs has not been solved to-date.
The existing approaches of CARPA prediction and prevention include consideration of drug-and other allergies, the use of premedication protocols with massive doses of steroids, non-steroidal anti-inflammatory agents and antihistamines, and slow infusion of reactogenic drugs (9, 10) . It is clear, however, that these approaches are neither fully effective, nor optimal. A previous clinical study has shown significant correlation between strong C activation in the blood of cancer patients treated with a reactogenic anticancer drug, Doxil, and the rise of CARPA in these patients (11) . Furthermore, a study in the present issue suggests that proneness for C activation by the reactogenic drug or by zymosan in the blood of cancer patients tested in vitro correlates with the symptoms of CARPA in vivo. These findings taken together suggest that pretreatment measurements of C activation in the blood of patients might serve as a predictive biomarker for CARPA.
However, a practical obstacle of realizing this approach is the slow and labor intensive, complicated measurement of C activation today, mostly with ELISA. Thus, there is a yet unfulfilled need for individualized prediction of the risk of CARPA with a rapid bedside bioassay. Despite wide interest and substantial industrial R&D for such a testing kit or device, to our best knowledge, the idea has not been realized to date. One of the problems lies in the use of relatively slow ELISA-based quantitation of C cleavage products as measures of C activation. The present study was conducted to explore the possibility of an alternative approach: quantitation of C activation via real-time tracing of MAC formation on SiO 2 -supported planar bilayer membranes (12) (13) (14) (15) (16) (17) as 
Materials and methods

Reagents
Human complement proteins C5b-6, C7, C8, and C9 were purchased from Complement Tech (TX, USA). Table 1 provides background information about these proteins and the concentrations used in the experimental protocols of this study. An aqueous buffer containing 10 mM Tris, 150 mM NaCl [pH 7.5] was used in all experiments. 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-Dioleoyl-sn-glycero-3-ethylphosphocholine (chloride salt) (DOEPC), and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-racglycerol) (sodium salt) (POPG) were purchased either in chloroform or powder form from Avanti Polar Lipids (Alabaster, AL, USA). Immediately before experiment, zwitterionic DOPC lipid powder was dissolved in isopropanol at the final concentration of 10 mg/mL. POPG and DOEPC lipid molecules were received in chloroform. First, the chloroform was evaporated with a stream of nitrogen air in order to create dried lipid films. Then, the dried lipid films were dissolved in appropriate organic solvent, e.g. ethanol or isopropanol. The negatively charged POPG lipids were dissolved to 5 mg/mL in ethanol at elevated temperature (at or above 40°C) in order to improve solubility. Prior to experiment, the desired lipid compositions were diluted to the experimental lipid concentration of 0.5 mg/mL.
Quartz crystal microbalance with dissipation (QCM-D) monitoring
QCM-D measurements were conducted using a Q-Sense E4 instrument equipped with flow modules (Q-Sense AB, Gothenburg, Sweden) in order to track the changes in resonance frequency (ΔF) and energy dissipation (ΔD) of an oscillating silicon oxide-coated quartz crystal. The crystal was excited at its fundamental resonance frequency of 5 MHz and odd overtones (n = 3, 5, 7, and 11) in order to generate the thickness shear mode. The reported data were recorded at the third overtone and all the experiments were performed under continuous flow conditions at a flow rate of 100 μL/min for bilayer formation and 41.8 μL/min for injection of MAC components, as controlled by a peristaltic pump.
Results
Charged lipid bilayer formation by solvent-assisted lipid bilayer (SALB) formation method
To study the effect of membrane electrostatic surface charge on MAC formation, we created planar bilayer membrane platforms with different surface charges by way of tuning the lipid composition. The synthetic lipid molecules used in the experiments included zwitterionic DOPC, cationic DOEPC and anionic POPG lipid. More specifically, 30% molar fraction of POPG or DOEPC lipid were mixed with the remaining fraction of DOPC lipids in order to make negatively or positively charged lipid bilayer membranes, respectively. Experiments were also conducted with 100% DOPC lipid composition. Figure 1B shows the representative QCM-D kinetic measurements for supported lipid bilayer formation on SiO 2 by the SALB formation method. Initially, the aqueous buffer solution (10 mM Tris, 150 mM NaCl, pH 7.5) was injected into the QCM-D measurement cell (Step 1) in order to establish stable baseline signals for the frequency and energy dissipation responses. After establishing the baselines, isopropanol solution was added into the measurement cell (
Step 2) which led to drastic changes in the frequency and energy dissipation signals during mixing isopropanol with buffer. During the mixing stage, the obtained dramatic changes mainly arise from the differences in density and viscosity of the buffer and isopropanol solutions, respectively. Afterwards, a freshly prepared 0. dissipation shift. In the final step, the isopropanol solution was gradually exchanged with buffer solution (Step 4) in order to form a complete planar lipid bilayer. Additionally, in order to check the completeness of the formed bilayer, 0.1 mg/mL BSA protein was finally added to detect nonspecific adhesion (Step 5). There was no significant change due to BSA protein adsorption in all cases, suggesting that high-quality lipid bilayers were formed in order to investigate MAC assembly. As quantitative measures, the changes in final frequency and dissipation values after bilayer formation and BSA adsorption are summarized in Table 2 . The obtained final frequency and dissipation values are consistent with the literature (16) (17) (18) . For rigid films such as a planar lipid bilayer, the sauerbrey equation is used to calculate the adsorbed mass on the substrate based on frequency shifts (19) . The attached mass on SiO 2 was approximately 450 ng/cm 2 after bilayer formation and was independent of lipid composition as shown in Figure  1C . In order to quantify the bilayer completion depending on lipid composition, the frequency shifts obtained by BSA adsorption on bare SiO 2 are normalized according the frequency shifts obtained by BSA adsorption on a planar lipid bilayer. The calculation indicated that bilayer completion was more than ∼97% complete irrespective of the lipid composition used to form the bilayer as shown in Figure 1D .
Initial strategy to form MAC assembly on SLBs
We first investigate the effect of membrane surface charge on MAC self-assembly on the planar lipid bilayer. The QCM-D signatures of the self-assembly of MAC components from the sequential addition of C5b-7, C8 and C9 proteins on three different types of lipid bilayer membranes are presented in Figure 2A and 2B. The initial measurement baseline was recorded during the validation of lipid bilayer quality via BSA adsorption and then normalized. Immediately before the injection of C5b-7 precomplex, 5 μg/mL of C5b-6 and 5 μg/mL of C7 protein precursors were incubated for 30 min in order to generate the C5b-7 precomplexed adduct at room temperature. Once the obtained precomplex was added onto the , respectively, whereas addition of the C5b-7 precomplex onto zwitterionic lipid bilayer membranes resulted in almost no binding based on the frequency and energy dissipation values. It has been previously reported that C5b-7 interacts with only negatively charged liposomes through a hydrophobic interaction (20) . Therefore, our find findings are consistent with the scientific literature.
After association of the C5b-7 precomplex into the lipid bilayers, 5 μg/mL of C8 protein was added onto the C5b-7 precomplex containing lipid bilayers ( Figure 2 , arrow 2). The variations in frequency and dissipation responses depended on the lipid composition, reflecting C5b-7 precomplex association. On negatively charged lipid bilayer membranes, the frequency and dissipation shifts due to the presence of C8 proteins were -6.1±1.0 Hz and 0.05±0.20 × 10 , respectively. Likewise, the frequency and dissipation shifts were negligible for both the positively charged and zwitterionic lipid bilayers ( < 2 Hz and ∼0.5 × 10
−6
). The interaction between the C5b-7 precomplex and C8 leads to formation of a C5b-8 intermediate complex on negatively charged lipid bilayers (21) . This interaction is crucial for further association of C9 proteins in order to make the MAC self-assembly.
Finally, 60 μg/mL C9 protein -the final MAC component -was injected to the membrane bound C5b-8 intermediate complex (Figure 2, arrow 3) . The absolute frequency and dissipation shifts on the negatively charged bilayer were -11.0±2.3 and 1.6±0.4 × 10 , respectively. However, there were no significant changes in frequency and dissipation responses obtained from the assembly of C9 proteins on both zwitterionic and positively charged lipid bilayers which is quite similar to the changes obtained from the association of the C5b-7 precomplex and C8 proteins. These small changes in frequency and dissipation of both positively charged and zwitterionic lipid bilayer membranes were caused by non-specific interactions between protein and the bilayer. The detailed schematic of MAC formation is presented in Figure 2C . The changes in absolute frequency, energy dissipation, and mass binding responses during the self-assembly of MAC components are presented in Table 3 . As a result, the obtained frequency and dissipation shifts were quite appreciable on negatively charged lipid bilayers. Therefore, negatively charged lipid bilayers were utilized for and DOPC (blue triangle) were used to determine the effects of membrane surface charge on MAC formation. After completion of the SALB procedure and validation of bilayer completeness, the previously incubated C5b-6 and C7 proteins were added in the form of a precomplex C5b-7 to the SLB platform. Then, C8 and C9 were added to the membrane-associated C5b-7 precomplex, respectively. (C) Schematic representation of MAC formation on the negatively charged SALB platform. The changes in final frequency and dissipation values were reported after the addition of individual MAC components in the order of C5b-7, C8 and C9, respectively. The C5b-7 precomplex was formed during a 30 min incubation of MAC initial precursors of C5b-6 and C7. The average and standard deviation of each measurement value are reported for three independent experiments.
further studies in order to investigate the molecular assembly of MAC components.
C5b-6 and C7 in MAC assembly
Individual C5b-6 and C7 protein precursors and the C5b-7 precomplex were utilized in order to further investigate the preferential association of these proteins on negatively charged lipid bilayers in order to initiate MAC selfassembly formation as shown in Figure 3 . First of all, after formation of the bilayer, 5 μg/mL of C5b-6 protein was added to the negatively charged lipid bilayer as shown in Figures 3A and 3B . Adsorption of C5b-6 onto the bilayer did not induce remarkable variations in both frequency and dissipation values. The association of C5b-6 to the cell surface is still unclear to date (22, 23) . It has been reported that C5b-6 loosely interacts with the cell membrane but the specific membrane molecules modulating this interaction are still unknown (22) . However, Silversmith et al. has reported that the composition of lipid vesicles determines the interaction of C5b-6 and C5b-7 complexes with liposomes based on light scattering intensity measurements (23, 24) . It was observed that liposomes formed by 100% phosphatidic acid (PA) or phosphatidylglycerol (PG) interacted with C5b-6, unlike liposomes composed phosphatidylcholine (PC), phosphatidylserine (PS), or phosphatidylinositol (PI) (23).
When C7 protein was added onto the negatively charged lipid bilayer, there were only minor changes, with frequency and energy dissipation shifts of only -2.5 Hz and less than 0.5 × 10 −6 , respectively. However, when C5b-6 interacts with C7, the C5b-7 precomplex spontaneously transferred from the solution to the targeted negatively charged SALB where it attaches to the lipid bilayer. Therefore, the frequency values increased almost 10-fold while changes in energy dissipation increased almost 6-fold compared to the individual association of C5b-6 and C7 proteins. The reported mechanism for interaction of the C5b-7 precomplex with the negatively charged lipid bilayer is the presence of an irreversible hydrophilic-amphiphilic transition during the interaction between C5b-6 and C7 protein precursors (21) . In other words, a conformational alteration occurs due to binding of C7 to C5b-6 which causes the exposure of an already existing internal hydrophobic domain with the surrounding environment. This alteration creates a bilayer targeting site in the C5b-7 precomplex which appears to involve the C7 protein even though the binding of individual C7 protein to negatively charged lipid bilayers is negligible (25) . In terms of affinity to the negatively charged lipid bilayer surface, it has been shown that the deposition level of the C5b-7 precomplex can also be enhanced by the presence of two sialylated molecules of erythrocyte membranes such as gangliosides and glycoporin through ionic interactions (26) . 
C8 in MAC assembly
The preferential association of C8 protein in the presence and absence of the C5b-7 complex on the lipid bilayer membrane surface was examined in order to demonstrate the formation of the C5b-8 intermediate complex as shown in Figure 4 . Once 5 μg of C8 protein was added to the bare lipid bilayer and the C5b-7 precomplex-containing lipid bilayer, the changes in frequency and dissipation responses were quite comparable ( Figure 4A, B) . The interaction of C8 with the bare lipid bilayer led to small changes in final frequency and dissipation responses (-5.1 Hz and 0.09 × 10 −6
, respectively). In the case of the presence of the C5b-7 precomplex on the lipid bilayer, the variations in frequency and dissipation responses were slightly different than in the absence of the C5b-7 precomplex. They were -6.8 Hz and 0.5 × 10
, respectively. It can be inferred that the changes in QCM-D responses were independent of the presence of the C5b-7 precomplex on the lipid bilayer. It has reported that the positively charged C8 protein interacts with the negatively charged C5b-7 precomplex. In other words, the interaction between C8 and the C5b-7 precomplex is driven by electrostatic interactions (27) . Therefore, it is not possible to confirm the formation of the C5b-8 intermediate complex based on obtained results because C8 would interact with the C5b-7 precomplex or the lipid bilayer itself as depicted in the schematic in Figure 4C . In order to prove the existence of C5b-8 precomplex, further investigation is necessary using C9 proteins.
Transformation of C9 monomer to MAC self-assembly complex
As a final test, 60 μg/mL of C9 protein was added to the negatively charged lipid bilayer in order to investigate the association of C9 in the presence and absence of C5b-8 intermediate complex. The changes in frequency and dissipation shifts are presented in Figure 5A ,B. In the absence of all MAC precursor proteins, C9 proteins interacted nonspecifically with the lipid bilayers so the changes in frequency and energy shifts were negligible and the obtained frequency and dissipation shifts were -3.1 Hz and 0.1 × 10 −6 , respectively. These small changes indicated that the nonspecific interaction of C9 did not affect the viscoelastic properties and integrity of the lipid bilayers. However, when the same concentration of C9 proteins was injected into the lipid bilayer which contains the C5b-8 intermediate complex, the variations in frequency and dissipation responses were about -14.0 Hz and 1.7 × 10 −6
, respectively. These appreciable changes designate the importance of the C5b-8 intermediate complex for association of C9 proteins. For example, the light scattering measurements were previously performed and the obtained light scattering intensity data showed that C9 did not interact with lipid vesicles unless the C5b-8 intermediate complex was present on the lipid vesicles (23) . In addition, C9 primarily interacts with C8 within the C5b-8 intermediate complex and this creates a C9 polymerization site which is essential for further MAC formation. 12-18 copies of C9 are necessary to polymerize circularly to create the MAC (28, 29) . If the concentration of C9 is lower, then C5b-9 forms due to the fact that the C9 polymerization stops before ring closure occurs (30) . The final MAC formation schematic is presented in Figure 5C . The presence of the C5b-8 intermediate complex on the lipid bilayer decreases the time required for C9 polymerization because it lowers the activation energy required for spontaneous polymerization of C9 (31, 32) . During this process, the hydrophilicamphiphilic transition occurs from the monomeric C9 to polymeric C9 complex which is able to insert the whole polymeric C9 complex itself into the hydrophobic core of the lipid bilayer. Based on our results, the initial association of C9 proteins to C5b-8 bound membrane occurred within 10 min, which might be preliminary evidence of C9 polymerization.
Discussion
Supported lipid bilayers constitute a two-dimensional membrane-mimicking surface that is compatible with a wide range of surface-sensitive measurement techniques, including acoustic and optical biosensors of various kinds (12, 13) . Supported lipid bilayers can be readily formed on silica-based materials by vesicle fusion (14) or solventassisted lipid bilayer (16) (SALB) formation methods, and the chemical composition of the bilayer can be adjusted, including electrical surface charge, membrane fluidity, and cholesterol content. For vesicle fusion, a variety of experimental conditions, including vesicle size (15), lipid composition (33), solution pH (34), osmotic pressure (35) , and freeze-thaw pretreatment (36) need to be optimized for reproducible bilayer fabrication which is difficult for non-expert users. On the other hand, the SALB process is a simpler and more versatile approach that involves lipid deposition in alcohol, followed by solvent-exchange with aqueous buffer. Its optimization is straightforward and supported lipid bilayers can be formed on a wide range of substrates, including gold, aluminum oxide, and titanium oxide in addition to silicon oxide (16, (37) (38) (39) (40) . Straightforward operation and high reproducibility lends strong potential for SALB fabrication approaches to serve as the basis for scale-up production of supported lipid bilayer platforms for clinical applications.
Importantly, in conjunction with label-free biosensing measurements, supported lipid bilayers enable quantitative kinetic tracking of molecular processes occurring on membrane interfaces. The quartz crystal microbalance with dissipation (QCM-D) monitoring technique has demonstrated significant promise for bioanalytical measurements by simultaneously recording changes in resonance frequency and energy dissipation of an oscillating quartz crystal due to a mass adsorbate (41) . The concept has been extended to molecular diagnostics in biological fluids, motivating the exploration of this measurement technique towards clinical applications, including high-sensitivity predictive detection of C activation.
Outlook
Herein, as an initial effort to design a CARPA predictor nanodevice, we demonstrated the assembly of MAC on silicon-oxide-supported, negatively charged lipid bilayer by the SALB formation method. By utilizing an acoustic sensor device, we were able to monitor MAC formation in real-time, thus obviating the need for ELISA measurement of C scission products as an endpoint of C activation. By doing so, we provided a promising new approach for real-time monitoring of C activation, one of the desired basic features of a potential bedside CARPA predictor nanodevice. Obviously however, intense further R&D will be needed to translate this advance into a clinically useful device which will differentiate between plasma proteins for selective response to MAC deposition only. An important question remains to verify whether detection of MAC formation requires sequential addition of C proteins or the simultaneous deposition of the implicated proteins is possible for more rapid measurement readout. Progress in this direction is currently underway in our laboratory.
